pindolol has been researched along with acebutolol in 79 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 46 (58.23) | 18.7374 |
1990's | 11 (13.92) | 18.2507 |
2000's | 13 (16.46) | 29.6817 |
2010's | 8 (10.13) | 24.3611 |
2020's | 1 (1.27) | 2.80 |
Authors | Studies |
---|---|
Carrupt, PA; el Tayar, N; Testa, B; Van de Waterbeemd, H | 1 |
Carrupt, PA; Gaillard, P; Schambel, P; Testa, B | 1 |
Topliss, JG; Yoshida, F | 1 |
Alvarez-Pedraglio, A; Colmenarejo, G; Lavandera, JL | 1 |
Gao, F; Lombardo, F; Obach, RS; Shalaeva, MY | 1 |
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Akamatsu, M; Fujikawa, M; Nakao, K; Shimizu, R | 1 |
Abraham, MH; Acree, WE; Ibrahim, A | 1 |
Carrupt, PA; Guillarme, D; Henchoz, Y; Rudaz, S; Veuthey, JL | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Ahman, M; Holmén, AG; Wan, H | 1 |
Bard, B; Carrupt, PA; Martel, S | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Du-Cuny, L; Mash, EA; Meuillet, EJ; Moses, S; Powis, G; Song, Z; Zhang, S | 1 |
Campillo, NE; Guerra, A; Páez, JA | 1 |
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
Gozalbes, R; Pineda-Lucena, A | 1 |
Akamatsu, M | 1 |
Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
Bellman, K; Knegtel, RM; Settimo, L | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Pfeifer, S; Zimmer, C | 1 |
Miesch, F; Schwartz, J; Spach, MO | 1 |
Gooren, L; Harms, HH; Hesse, C; Spoelstra, AJ; Verschoor, L | 1 |
Wilcox, RG | 1 |
Kiechel, JR; Meier, J | 1 |
Tannenbaum, H | 1 |
Fillastre, JP; Godin, M | 1 |
Emeriau, JP; Rumeau, M | 1 |
Dubois, D; Petitcolas, J | 1 |
Dubach, UC | 1 |
Cherchi, A; Sau, F; Seguro, C | 1 |
Hansen, JE; Kayser, L; Perrild, H; Petersen, PH; Skovsted, L | 1 |
Basciu, M; Cherchi, A; Pili, G; Sau, F; Seguro, C; Siddi, PP; Tamponi, R | 1 |
Lehtonen, A | 2 |
Beudin, P; Ducher, JL; Gibert, J; Kantelip, JP; Lauxerois, M; Pechadre, JC; Sabot, C; Trolese, JF | 1 |
Carlsen, JE; McNair, A; Svendsen, TL; Trap-Jensen, J | 1 |
Hattori, M; Miyazaki, Y; Nagai, S; Ozawa, T; Sugiyama, S | 1 |
Bennet, P; Bosquet, F; Chapelon, C; Delas, B; Grimaldi, A; Lebargy, F; Sobel, J | 1 |
de Boo, T; Lemmens, WA; Lenders, JW; Salemans, J; Thien, T; van't Laar, A | 1 |
Fishbein, L; Jackson, CD | 1 |
Gordin, A; Sundberg, S | 1 |
Barberis, S; Galietti, F; Giorgis, GE; Massaglia, GM; Miravalle, C; Onoscuri, E | 1 |
Albengres, E; Duche, JC; Riant, P; Tillement, JP; Urien, S | 1 |
Feldt-Rasmussen, U; Kayser, L; Mølholm Hansen, J; Perrild, H | 1 |
Dueymes, M; Fournié, GJ; In, S | 1 |
Halawa, B | 1 |
Boomsma, F; Man in 't Veld, AJ; Schalekamp, MA; van den Meiracker, AH; van Eck, HJ | 1 |
Clucas, A; Miller, N | 1 |
Franz, IW; Röcker, L | 1 |
Ban, T; Sada, H | 1 |
Franz, IW; Lohmann, FW | 1 |
Drayer, JI; Weber, MA | 1 |
Attuel, P; Coumel, P; Kural, S; Leclercq, JF; Rosengarten, MD | 1 |
Borer, JS; Moses, JW | 1 |
Hedges, A; Kilfeather, S; Lima, DR; Turner, P | 1 |
Bender, F; Gülker, H; Heuer, H; Kristek, J | 1 |
Brotelle, R; Colot, M; de Clavière, M; Heyndrickx, JP | 1 |
Delaigue-Fabry, R; Duchene-Marullaz, P; Eschalier, A; Kantelip, JP | 1 |
Behrenbeck, DW; Braun, V; Gil-Sanchez, D; Hilger, HH; Hombach, V; Höpp, HW; Tauchert, M | 1 |
Catherine, P; Dubois, D; Klepper, A; Petitcolas, J; Temperville, B | 1 |
Bolte, HD | 1 |
Franz, IW; Koch, G; Lohmann, FW; Quabbe, HJ | 1 |
Kolsky, H; Moisson, P; Philippe, B; Witchitz, S | 1 |
Franz, IW; Gubba, A; Koch, G; Lohmann, FW | 1 |
Lil'in, ET; Mar'in, MI; Vavilova, TA | 1 |
Miyazaki, Y; Nagai, S; Ogawa, K; Ozawa, T; Satake, T; Sugiyama, S | 1 |
Franz, IW; Koch, G; Lohmann, FW | 1 |
Klug, S; Merker, HJ; Neubert, D; Schwabe, R; Thiel, R | 1 |
Pargentino, E; Sau, F; Seguro, C | 1 |
Hasegawa, R; Kimura, T; Murai-Kushiya, M; Okada, S | 1 |
Kim, Y | 1 |
Caldwell, GW; Evangelisto, M; Masucci, JA; White, R | 1 |
Caldwell, GW; Demarest, K; Easlick, SM; Gunnet, J; Masucci, JA | 1 |
Black, M; Cayenne, S; Cohen, TJ; Doolittle, S; Ibrahim, B; Quan, W | 1 |
Arima, Y; Hasegawa, C; Izawa, H; Kumazawa, T; Lee, XP; Sato, K; Umezawa, H | 1 |
Pisklak, DM; Wawer, I; Zielińska-Pisklak, MA | 1 |
Dormuth, C; Musini, VM; Soufi, S; Zhang, XY | 1 |
12 review(s) available for pindolol and acebutolol
Article | Year |
---|---|
Modeling of beta-adrenoceptors based on molecular electrostatic potential studies of agonists and antagonists.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Models, Molecular; Receptors, Adrenergic, beta; Structure-Activity Relationship | 1988 |
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
[Biotransformation and pharmacokinetics of beta-receptor blockaders].
Topics: Acebutolol; Adrenergic beta-Antagonists; Alprenolol; Animals; Biotransformation; Ethanolamines; Humans; Isoproterenol; Kinetics; Levobunolol; Oxprenolol; Pindolol; Practolol; Propanolamines; Propranolol; Sotalol | 1975 |
[Comparative pharmacokinetics of beta-blockers].
Topics: Acebutolol; Adrenergic beta-Antagonists; Alprenolol; Animals; Atenolol; Half-Life; Humans; Metoprolol; Oxprenolol; Pindolol; Practolol; Propranolol; Sotalol; Timolol | 1978 |
[Long-term utilization of beta-blockers in arterial hypertension].
Topics: Acebutolol; Adrenergic beta-Antagonists; Alprenolol; Blood Pressure; Coronary Disease; Drug Tolerance; Heart Rate; Humans; Hypertension; Metoprolol; Pindolol; Practolol; Time Factors | 1978 |
Effects of beta-blockers on plasma lipids during antihypertensive therapy.
Topics: Acebutolol; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Cholesterol, HDL; Humans; Hypertension; Lipids; Phosphatidylcholine-Sterol O-Acyltransferase; Pindolol | 1985 |
A toxicological review of beta-adrenergic blockers.
Topics: Acebutolol; Adrenergic beta-Antagonists; Alprenolol; Animals; Atenolol; Cocarcinogenesis; Ethanolamines; Female; Kinetics; Labetalol; Lethal Dose 50; Male; Metoprolol; Mice; Mutagens; Nadolol; Neoplasms, Experimental; Oxprenolol; Pindolol; Practolol; Propanolamines; Propranolol; Rats; Sotalol; Timolol | 1986 |
Effects of acebutolol on the serum lipid profile.
Topics: Acebutolol; Cholesterol; Humans; Lipoproteins; Penbutolol; Pindolol; Propranolol; Triglycerides | 1988 |
Beta-adrenergic antagonists in the treatment of patients with heart disease.
Topics: Acebutolol; Adrenergic beta-Agonists; Alprenolol; Animals; Arrhythmias, Cardiac; Bronchial Spasm; Cardiomyopathy, Hypertrophic; Coronary Disease; Female; Heart Diseases; Heart Failure; Humans; Hypertension; Metoprolol; Mitral Valve Prolapse; Mitral Valve Stenosis; Nadolol; Nervous System Diseases; Pindolol; Pregnancy; Pregnancy Complications, Cardiovascular; Propanolamines; Propranolol; Receptors, Adrenergic, beta; Structure-Activity Relationship; Timolol | 1981 |
Aspects of hormonal regulation of lipolysis during exercise: effects of chronic beta-receptor blockade.
Topics: Acebutolol; Adrenergic beta-Antagonists; Adrenocorticotropic Hormone; Adult; Catecholamines; Fatty Acids, Nonesterified; Glycerol; Growth Hormone; Humans; Hypertension; Insulin; Lipolysis; Male; Physical Exertion; Pindolol; Sports Medicine; Thyrotropin; Time Factors | 1983 |
[Relation between the effect of sectral and visken in stage 2 hypertension patients and the sensitivity of the nervous system].
Topics: Acebutolol; Adrenergic beta-Antagonists; Adult; Antihypertensive Agents; Female; Humans; Hypertension; Male; Middle Aged; Pindolol | 1983 |
Time course for blood pressure lowering of beta-blockers with partial agonist activity.
Topics: Acebutolol; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Adult; Antihypertensive Agents; Bias; Blood Pressure; Circadian Rhythm; Controlled Clinical Trials as Topic; Female; Heart Rate; Humans; Hypertension; Male; Middle Aged; Pindolol; Time Factors | 2020 |
10 trial(s) available for pindolol and acebutolol
Article | Year |
---|---|
Randomised study of six beta-blockers and a thiazide diuretic in essential hypertension.
Topics: Acebutolol; Adrenergic beta-Antagonists; Adult; Atenolol; Bendroflumethiazide; Clinical Trials as Topic; Female; Humans; Hypertension; Labetalol; Male; Middle Aged; Pindolol; Propranolol; Random Allocation; Timolol | 1978 |
[Electrocardiographic and echocardiographic changes during antihypertensive therapy].
Topics: Acebutolol; Adolescent; Adult; Aged; Antihypertensive Agents; Captopril; Cardiomegaly; Chlorthalidone; Echocardiography; Electrocardiography; Female; Humans; Hypertension; Indenes; Male; Middle Aged; Nifedipine; Oxprenolol; Pindolol; Propanolamines; Timolol | 1990 |
[Central effects of five beta-adrenergic receptor blockers in healthy volunteers: a quantitative EEG study].
Topics: Acebutolol; Adrenergic beta-Antagonists; Adult; Brain; Carteolol; Electroencephalography; Humans; Male; Metoprolol; Monitoring, Physiologic; Pindolol; Sotalol | 1989 |
The influence of intrinsic sympathomimetic activity and beta-1 receptor selectivity on the recovery of finger skin temperature after finger cooling in normotensive subjects.
Topics: Acebutolol; Administration, Oral; Adrenergic beta-Antagonists; Adult; Atenolol; Blood Pressure; Cold Temperature; Double-Blind Method; Drug Evaluation; Female; Fingers; Forearm; Heart Rate; Humans; Male; Pindolol; Propranolol; Random Allocation; Skin Temperature | 1986 |
Influence of beta blockade and intrinsic sympathomimetic activity on hemodynamics, inotropy and respiration at rest and during exercise.
Topics: Acebutolol; Adolescent; Adrenergic beta-Antagonists; Adult; Clinical Trials as Topic; Double-Blind Method; Female; Hemodynamics; Humans; Male; Nadolol; Physical Exertion; Pindolol; Propanolamines; Random Allocation; Respiration; Rest; Spirometry; Sympathetic Nervous System; Systole | 1986 |
Effect of chronic beta-adrenergic blockade on exercise-induced leukocytosis.
Topics: Acebutolol; Adult; Humans; Hypertension; Leukocyte Count; Leukocytosis; Lymphocytes; Male; Neutrophils; Physical Exertion; Pindolol | 1986 |
[Differential effect of long-term beta1-selective and nonselective beta-receptor blockade on carbohydrate metabolism. Ergometric investigations in hypertensive patients (author's transl)].
Topics: Acebutolol; Adrenergic beta-Antagonists; Adrenocorticotropic Hormone; Adult; Blood Glucose; Blood Pressure; Carbohydrate Metabolism; Gluconeogenesis; Heart Rate; Humans; Hypertension; Insulin; Male; Physical Exertion; Pindolol | 1980 |
Aspects of hormonal regulation of lipolysis during exercise: effects of chronic beta-receptor blockade.
Topics: Acebutolol; Adrenergic beta-Antagonists; Adrenocorticotropic Hormone; Adult; Catecholamines; Fatty Acids, Nonesterified; Glycerol; Growth Hormone; Humans; Hypertension; Insulin; Lipolysis; Male; Physical Exertion; Pindolol; Sports Medicine; Thyrotropin; Time Factors | 1983 |
beta-adrenoceptor blockade and physical activity: cardiovascular and metabolic aspects.
Topics: Acebutolol; Adrenergic beta-Antagonists; Adult; Blood Glucose; Catecholamines; Hemodynamics; Humans; Hypertension; Lactates; Lactic Acid; Lipolysis; Male; Metoprolol; Oxygen Consumption; Physical Exertion; Pindolol; Pituitary Hormones, Anterior; Respiration | 1983 |
Effects of short-term and long-term treatment with cardio-selective and non-selective beta-receptor blockade on carbohydrate and lipid metabolism and on plasma catecholamines at rest and during exercise.
Topics: Acebutolol; Adult; Blood Glucose; Dopamine; Epinephrine; Humans; Hypertension; Lipids; Long-Term Care; Metoprolol; Pindolol; Propanolamines | 1981 |
58 other study(ies) available for pindolol and acebutolol
Article | Year |
---|---|
Binding of arylpiperazines, (aryloxy)propanolamines, and tetrahydropyridylindoles to the 5-HT1A receptor: contribution of the molecular lipophilicity potential to three-dimensional quantitative structure-affinity relationship models.
Topics: Indoles; Ligands; Models, Molecular; Molecular Conformation; Molecular Structure; Piperazines; Propanolamines; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Serotonin; Structure-Activity Relationship; Tetrahydronaphthalenes | 1996 |
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Cheminformatic models to predict binding affinities to human serum albumin.
Topics: Adrenergic beta-Antagonists; Antidepressive Agents, Tricyclic; Chromatography, Affinity; Cyclooxygenase Inhibitors; Databases, Factual; Humans; Hydrophobic and Hydrophilic Interactions; Penicillins; Pharmaceutical Preparations; Protein Binding; Quantitative Structure-Activity Relationship; Reproducibility of Results; Serum Albumin; Steroids | 2001 |
Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics.
Topics: Algorithms; Blood Proteins; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding; Statistics as Topic; Tissue Distribution | 2004 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
QSAR study on permeability of hydrophobic compounds with artificial membranes.
Topics: Biological Transport; Caco-2 Cells; Drug Evaluation, Preclinical; Humans; Hydrophobic and Hydrophilic Interactions; Membranes, Artificial; Permeability; Pharmaceutical Preparations; Quantitative Structure-Activity Relationship | 2007 |
Air to lung partition coefficients for volatile organic compounds and blood to lung partition coefficients for volatile organic compounds and drugs.
Topics: Air; Animals; Humans; Lung; Organic Chemicals; Probability; Rats; Tissue Distribution; Volatilization | 2008 |
High-throughput log P determination by ultraperformance liquid chromatography: a convenient tool for medicinal chemists.
Topics: Chemical Phenomena; Chemistry, Pharmaceutical; Chemistry, Physical; Chromatography, Liquid; Mathematics; Pharmaceutical Preparations; Software | 2008 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Relationship between brain tissue partitioning and microemulsion retention factors of CNS drugs.
Topics: Brain; Central Nervous System; Chromatography, Liquid; Emulsions; Mass Spectrometry | 2009 |
Lipophilicity of basic drugs measured by hydrophilic interaction chromatography.
Topics: Chemistry, Pharmaceutical; Chromatography; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Pharmaceutical Preparations; Solubility; Technology, Pharmaceutical | 2009 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Computational modeling of novel inhibitors targeting the Akt pleckstrin homology domain.
Topics: Antineoplastic Agents; Blood Proteins; Caco-2 Cells; Cell Membrane Permeability; Computer Simulation; Drug Discovery; Drug Screening Assays, Antitumor; Humans; Models, Molecular; Phosphoproteins; Protein Binding; Protein Kinase Inhibitors; Protein Structure, Tertiary; Proto-Oncogene Proteins c-akt; Quantitative Structure-Activity Relationship | 2009 |
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
QSAR-based solubility model for drug-like compounds.
Topics: Databases, Factual; Models, Molecular; Pharmaceutical Preparations; Quantitative Structure-Activity Relationship; Solubility; Water | 2010 |
Importance of physicochemical properties for the design of new pesticides.
Topics: Anabasine; Animals; Biological Availability; Cell Membrane Permeability; Chemical Phenomena; Drug Design; Humans; Imidazoles; Insecticides; Neonicotinoids; Nitro Compounds; Pesticides; Quantitative Structure-Activity Relationship; Receptors, Nicotinic | 2011 |
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
[Comparison of the pA2 of various beta blocking agents].
Topics: Acebutolol; Adrenergic beta-Antagonists; Alprenolol; Animals; Dose-Response Relationship, Drug; Guinea Pigs; Heart Atria; In Vitro Techniques; Oxprenolol; Pindolol; Practolol; Propranolol; Trachea | 1975 |
Blockade of isoprenaline-induced changes in plasma free fatty acids, immunoreactive insulin levels and plasma renin activity in healthy human subjects, by propranolol, pindolol, practolol, atenolol, metoprolol and acebutolol.
Topics: Acebutolol; Adrenergic beta-Antagonists; Adult; Atenolol; Blood Pressure; Fatty Acids, Nonesterified; Heart Rate; Humans; Insulin; Isoproterenol; Male; Metoprolol; Pindolol; Practolol; Propranolol; Renin | 1978 |
[Treatment by beta-blockers of arterial hypertension in patients with chronic renal insufficiency on hemodialysis].
Topics: Acebutolol; Adrenergic beta-Antagonists; Humans; Hypertension, Renal; Kidney Failure, Chronic; Pindolol; Propranolol; Renal Dialysis | 1978 |
[Beta-blockers and arterial hypertension in the aged patient].
Topics: Acebutolol; Adrenergic beta-Antagonists; Aged; Electrocardiography; Female; Heart Rate; Humans; Hypertension; Male; Pindolol; Timolol | 1978 |
[beta-blockers and high risk pregnancies. Viewpoint of the nephrologist and the obstetrician].
Topics: Acebutolol; Adrenergic beta-Antagonists; Female; Humans; Hypertension; Pindolol; Pregnancy; Pregnancy Complications, Cardiovascular; Propranolol | 1978 |
[Editorial: Importance of cardioselectivity and sympaticomimetric potential of beta-blockers (author's transl)].
Topics: Acebutolol; Adrenergic beta-Antagonists; Alprenolol; Blood Vessels; Ethanolamines; Heart; Humans; Oxprenolol; Pindolol; Practolol; Propranolol; Sotalol; Sympathomimetics | 1975 |
[Effects of antihypertensive therapy with selective and non-selective beta blocking agents on dimensions and function of the left ventricle].
Topics: Acebutolol; Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Atenolol; Blood Pressure; Echocardiography; Female; Heart Ventricles; Hemodynamics; Humans; Hypertension; Male; Middle Aged; Nadolol; Pindolol; Timolol; Ventricular Function | 1991 |
Acute beta-blockade changes the extracellular distribution of thyroid hormones.
Topics: Acebutolol; Adrenergic beta-Antagonists; Adult; alpha-Macroglobulins; Carrier Proteins; Female; Humans; Male; Membrane Proteins; Middle Aged; Oxprenolol; Pindolol; Serum Albumin; Thyroid Hormone-Binding Proteins; Thyroid Hormones; Thyroxine; Timolol; Tissue Distribution; Triiodothyronine | 1990 |
Immediate central hemodynamic effects of five different beta-adrenoceptor-blocking agents, acebutolol, atenolol, pindolol, practolol, and propranolol, in patients with ischemic heart disease.
Topics: Acebutolol; Adrenergic beta-Antagonists; Aged; Atenolol; Cardiac Output; Coronary Disease; Heart Rate; Hemodynamics; Humans; Male; Middle Aged; Pindolol; Practolol; Propranolol | 1985 |
Effect of beta blockers on blood lipid profile.
Topics: Acebutolol; Adrenergic beta-Antagonists; Apolipoproteins; Cholesterol; Cholesterol, HDL; Humans; Hypertension; Lipids; Pindolol | 1985 |
Mechanism of antiarrhythmic action of beta-blocking agents.
Topics: Acebutolol; Acyl Coenzyme A; Adrenergic beta-Antagonists; Animals; Arrhythmias, Cardiac; Calcium; Cardiac Pacing, Artificial; Coronary Vessels; Dogs; Female; Heart; Ligation; Male; Mitochondria, Heart; Pindolol; Premedication; Propranolol | 1985 |
[Betablockers and hypoglycemia].
Topics: Acebutolol; Adrenergic beta-Antagonists; Adult; Blood Glucose; Female; Humans; Hypoglycemia; Insulin; Insulin, Regular, Pork; Kinetics; Male; Pindolol | 1985 |
[Possibilities of using cardioselective beta blocking agents in patients with chronic obstructive bronchopneumopathies].
Topics: Acebutolol; Adrenergic beta-Antagonists; Aerosols; Aged; Atenolol; Blood Pressure; Female; Forced Expiratory Volume; Heart Rate; Humans; Lung Diseases, Obstructive; Male; Metaproterenol; Middle Aged; Pindolol; Propranolol | 1986 |
High plasma protein binding as a parameter in the selection of betablockers for lactating women.
Topics: Acebutolol; Adrenergic beta-Antagonists; Blood Proteins; Female; Humans; Hypertension; Lactation; Milk, Human; Pindolol; Pregnancy; Propanolamines; Propranolol; Protein Binding; Sotalol | 1986 |
Short-term beta-adrenergic blockade decreases serum thyroglobulin in hyper- and euthyroid patients.
Topics: Acebutolol; Adrenergic beta-Antagonists; Adult; Aged; Female; Humans; Hyperthyroidism; Male; Middle Aged; Oxprenolol; Pindolol; Thyroglobulin | 1986 |
Beta blockers may induce in C57BL/6 mice a polyclonal activation of lymphocytes which is not mediated by beta adrenergic receptors.
Topics: Acebutolol; Adrenergic beta-Antagonists; Animals; Female; Immunity, Cellular; Immunoglobulins; Lymphocyte Activation; Mice; Mice, Inbred C57BL; Pindolol; Receptors, Adrenergic, beta; Stereoisomerism | 1988 |
[Effect of treatment with pindolol, acebutolol and propranolol on the density of beta-adrenergic receptors in human lymphocytes].
Topics: Acebutolol; Adult; Angina Pectoris; Humans; Hypertension; Lymphocytes; Male; Middle Aged; Pindolol; Propranolol; Receptors, Adrenergic, beta | 1987 |
Hemodynamic and hormonal adaptations to beta-adrenoceptor blockade. A 24-hour study of acebutolol, atenolol, pindolol, and propranolol in hypertensive patients.
Topics: Acebutolol; Atenolol; Hemodynamics; Humans; Hypertension; Male; Middle Aged; Norepinephrine; Pindolol; Propranolol; Renin; Time Factors; Vasodilation | 1988 |
Effects of acebutolol and other structurally related beta adrenergic blockers on transmembrane action potential in guinea-pig papillary muscles.
Topics: Acebutolol; Action Potentials; Adrenergic beta-Antagonists; Animals; Female; Guinea Pigs; In Vitro Techniques; Ion Channels; Male; Oxprenolol; Papillary Muscles; Pindolol; Sodium; Structure-Activity Relationship | 1980 |
Renal effects of beta-adrenoceptor blockade.
Topics: Acebutolol; Adrenergic beta-Antagonists; Alprenolol; Angiotensin II; Animals; Blood Pressure; Cardiac Output; Glomerular Filtration Rate; Humans; Hypertension; Kidney; Pindolol; Propranolol; Renin; Sodium | 1980 |
Effects of intrinsic sympathetic activity of beta-blockers on SA and AV nodes in man.
Topics: Acebutolol; Adrenergic beta-Antagonists; Atrial Fibrillation; Atrioventricular Node; Circadian Rhythm; Heart Conduction System; Heart Rate; Humans; Pindolol; Propranolol; Sinoatrial Node; Sympathetic Nervous System | 1981 |
Comparison of four different beta-adrenoceptor blocking drugs on lymphocyte isoprenaline-stimulated cyclic AMP production.
Topics: Acebutolol; Adrenergic beta-Antagonists; Adult; Atenolol; Cyclic AMP; Drug Interactions; Female; Humans; Isoproterenol; Lymphocytes; Male; Middle Aged; Pindolol; Timolol | 1981 |
Sympathomimetic and cardiodepressant effects of acebutolol, oxprenolol, pindolol, and propranolol. A comparative study on changes in hemodynamics, contractility, heart rate, and AV-conduction time at therapeutic doses.
Topics: Acebutolol; Adrenergic beta-Antagonists; Animals; Anti-Arrhythmia Agents; Atrioventricular Node; Dogs; Heart Rate; Hemodynamics; Humans; Infant, Newborn; Myocardial Contraction; Oxprenolol; Pindolol; Propranolol; Sympathomimetics | 1981 |
Variability in the preventive action of the B-blockers on genetic hypertension in the rat.
Topics: Acebutolol; Adrenergic beta-Antagonists; Alprenolol; Animals; Blood Pressure; Dose-Response Relationship, Drug; Hypertension; Male; Metoprolol; Oxprenolol; Pindolol; Practolol; Propranolol; Rats; Rats, Inbred Strains; Species Specificity; Time Factors | 1980 |
Comparison of the effects of propranolol, pindolol, oxprenolol and acebutolol on atrioventricular conduction in unanaesthetized dogs.
Topics: Acebutolol; Adrenergic beta-Antagonists; Animals; Atrioventricular Node; Atropine; Blood Pressure; Dogs; Female; Heart Conduction System; Heart Rate; Male; Oxprenolol; Pentobarbital; Pindolol; Propranolol | 1982 |
Electrophysiological effects of cardioselective and non-cardioselective beta-adrenoceptor blockers with and without ISA at rest and during exercise.
Topics: Acebutolol; Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Atenolol; Electrophysiology; Female; Heart; Heart Conduction System; Heart Rate; Humans; Male; Middle Aged; Physical Exertion; Pindolol; Rest; Sympathomimetics | 1982 |
Treatment of hypertension in pregnancy with beta-adrenoceptor antagonists.
Topics: Abnormalities, Drug-Induced; Acebutolol; Adrenergic beta-Antagonists; Adult; Apgar Score; Atenolol; Birth Weight; Female; Humans; Hypertension; Pindolol; Pregnancy; Pregnancy Complications, Cardiovascular; Resuscitation | 1982 |
[Beta receptor blockaders. Pharmacokinetics and therapeutic effects].
Topics: Acebutolol; Adrenergic beta-Antagonists; Animals; Biological Availability; Guinea Pigs; Humans; Kinetics; Pindolol; Propranolol; Timolol | 1982 |
[Beta-blockers in effort angina].
Topics: Acebutolol; Adrenergic beta-Antagonists; Adult; Aged; Angina Pectoris; Drug Therapy, Combination; Exercise Test; Female; Follow-Up Studies; Humans; Male; Middle Aged; Pindolol; Propranolol; Sympathomimetics; Vasodilator Agents | 1983 |
The effects of beta-blocking agents on mitochondrial function in ischemic myocardium.
Topics: Acebutolol; Acyl Coenzyme A; Adrenergic beta-Antagonists; Animals; Coronary Disease; Dogs; Female; Isoproterenol; Male; Mitochondria, Heart; Oxygen Consumption; Pindolol; Propranolol; Stereoisomerism | 1984 |
Toxicity of beta-blockers in a rat whole embryo culture: concentration-response relationships and tissue concentrations.
Topics: Acebutolol; Adrenergic beta-Antagonists; Alprenolol; Animals; Atenolol; Dose-Response Relationship, Drug; Embryo, Mammalian; Embryonic and Fetal Development; In Vitro Techniques; Metoprolol; Pindolol; Propranolol; Rats; Rats, Wistar | 1994 |
[Chronology of regression of hypertensive ventricular hypertrophy during antihypertensive therapy with beta blockers].
Topics: Acebutolol; Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Antihypertensive Agents; Echocardiography; Female; Hemodynamics; Humans; Hypertension; Hypertrophy, Left Ventricular; Indenes; Male; Middle Aged; Oxprenolol; Pindolol; Propanolamines; Time Factors | 1994 |
Stereoselective binding of beta-blockers to purified rat alpha 1-acid glycoprotein.
Topics: Acebutolol; Adrenergic beta-Antagonists; Animals; Blood Proteins; Dialysis; Male; Orosomucoid; Pindolol; Propranolol; Protein Binding; Rats; Rats, Wistar; Stereoisomerism | 1993 |
Interaction between beta blockers and epinephrine on hemodynamics of spontaneously hypertensive rats.
Topics: Acebutolol; Adult; Animals; Body Weight; Drug Interactions; Epinephrine; Female; Hemodynamics; Humans; Lidocaine; Lung; Male; Pindolol; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Species Specificity | 1993 |
Evaluation of the immobilized artificial membrane phosphatidylcholine. Drug discovery column for high-performance liquid chromatographic screening of drug-membrane interactions.
Topics: Acebutolol; Acetonitriles; Adrenergic beta-Antagonists; Alprenolol; Aniline Compounds; Atenolol; Chromatography, High Pressure Liquid; Hydrogen-Ion Concentration; Membranes, Artificial; Metoprolol; Models, Chemical; Osmolar Concentration; Oxprenolol; Phosphatidylcholines; Pindolol; Propranolol; Reproducibility of Results; Timolol | 1998 |
In vitro permeability of eight beta-blockers through Caco-2 monolayers utilizing liquid chromatography/electrospray ionization mass spectrometry.
Topics: Acebutolol; Adrenergic beta-Antagonists; Alprenolol; Atenolol; Biological Availability; Caco-2 Cells; Cell Membrane Permeability; Chromatography, Liquid; Epithelial Cells; Humans; Intestinal Absorption; Intestinal Mucosa; Mass Spectrometry; Metoprolol; Molecular Structure; Oxprenolol; Pindolol; Propranolol; Research Design; Timolol | 1998 |
The effects of intrinsic sympathomimetic activity on beta-blocker efficacy for treatment of neurocardiogenic syncope.
Topics: Acebutolol; Adrenergic beta-Antagonists; Adult; Aged; Atenolol; Female; Humans; Male; Metoprolol; Middle Aged; Pindolol; Retrospective Studies; Sympathomimetics; Syncope, Vasovagal; Tilt-Table Test | 1999 |
Simultaneous determination of beta-blockers in human plasma using liquid chromatography-tandem mass spectrometry.
Topics: Acebutolol; Adrenergic beta-Antagonists; Chromatography, Liquid; Humans; Labetalol; Linear Models; Metoprolol; Pindolol; Propranolol; Sensitivity and Specificity; Tandem Mass Spectrometry | 2008 |
1H and 13C NMR characteristics of β-blockers.
Topics: Acebutolol; Acids; Adrenergic beta-Antagonists; Alkalies; Alprenolol; Atenolol; Carbazoles; Carbon Isotopes; Carvedilol; Nuclear Magnetic Resonance, Biomolecular; Pindolol; Propanolamines; Propranolol; Protons; Timolol | 2011 |